CorVel Corporation (NASDAQ: CRVL) — Form 10-Q Summary
Period clarification: Although the request metadata identifies “2020 Q3,” this filing covers the quarter and nine months ended December 31, 2021 (CorVel’s fiscal 2022 third quarter), compared with the periods ended December 31, 2020. The filing was signed February 3, 2022.
Business context
CorVel provides managed-care and medical cost-containment services, primarily for workers’ compensation, auto insurance, and group health claims. It reports one operating segment, managed care, with two service lines: patient management and network solutions.
Financial performance
| Metric | Three months ended Dec. 31, 2021 | Three months ended Dec. 31, 2020 | Nine months ended Dec. 31, 2021 | Nine months ended Dec. 31, 2020 |
|---|---|---|---|---|
| Revenue | $164.5 million | $141.5 million | $474.9 million | $407.1 million |
| Gross profit / margin | $35.2 million / 21.4% | $30.9 million / 21.8% | $109.1 million / 23.0% | $87.9 million / 21.6% |
| Income before taxes | $17.7 million | $14.0 million | $58.3 million | $39.8 million |
| Net income | $13.9 million | $11.4 million | $46.8 million | $31.5 million |
| Diluted EPS | $0.76 | $0.63 | $2.57 | $1.74 |
| Operating cash flow | Not separately reported | Not separately reported | $50.4 million | $73.8 million |
- Quarterly revenue grew 16.3%; net income rose 21.8% and diluted EPS rose 20.6%. Nine-month revenue grew 16.6%, net income 48.3%, and diluted EPS 47.7%.
- Quarterly patient management revenue increased 11.6% to $107.7 million; network solutions revenue increased 26.4% to $56.8 million. For nine months, the respective increases were 15.0% and 19.9%.
- Quarterly gross margin declined 0.4 percentage points year over year, while nine-month gross margin improved 1.4 points. Quarterly pretax margin increased to 10.7% from 9.9%; nine-month pretax margin increased to 12.3% from 9.8%.
- Quarterly effective tax rate was 21.6%, versus 18.5%; the nine-month rate was 19.8%, versus 21.0%.
Liquidity, cash flow, and capital
- At December 31, 2021, cash and cash equivalents were $115.5 million, total current assets $268.7 million, total current liabilities $170.5 million, and working capital $98.1 million. Cash declined $24.2 million from March 31, 2021.
- Nine-month operating cash flow was $50.4 million, down from $73.8 million. Management attributed the decrease principally to the prior-year CARES Act payroll-tax deferral and higher receivables as revenue grew.
- Capital expenditures were $18.4 million, versus $13.3 million. Financing cash outflow was $56.1 million, driven mainly by $65.3 million of share repurchases.
- The company had no debt outstanding. Lease liabilities totaled $52.1 million at December 31, 2021; an additional approximately $5.2 million of operating lease commitments had not yet commenced.
- Management said cash and expected internally generated funds should cover expected requirements for at least 12 months. It may reduce or suspend repurchases if income or cash flows weaken.
Material changes, outlook, and risks
- Management attributed revenue growth mainly to economic recovery from pandemic disruptions, higher activity from existing customers, and, to a lesser extent, new customers. New claims rose 6% in the quarter and 14% over nine months year over year. Field-operations headcount increased 15% to support higher business volumes.
- Quarterly cost of revenue grew 16.9%, slightly faster than revenue, reflecting volume and higher field salaries. G&A grew 3.4%; nine-month G&A grew 5.7%, with increased marketing, software development, headcount, and consulting costs.
- No specific revenue, earnings, or margin guidance is provided. The filing cautions that interim results are not necessarily indicative of full-year results.
- COVID-19 effects were described as having decreased over time, but management warned that the pandemic and uneven recovery could still adversely affect customer demand, claims activity, operations, and cash flows. Most employees continued working remotely; the company also revised certain lease-renewal assumptions in light of expected lower office-space needs.
- Key disclosed risks include competition and customer insourcing, changes in workers’ compensation claims and outsourcing demand, labor and benefit-cost pressure, technology investment and execution, cybersecurity and privacy incidents, regulation, and litigation or professional-liability exposure. Management said ordinary-course litigation was not expected to result in material payments.
- The company repurchased 420,082 shares for $65.3 million during the nine months, at an average $155.42 per share; 926,366 shares remained authorized for repurchase at quarter-end. It repurchased a further 42,629 shares for $8.0 million after quarter-end. The filing notes buybacks reduce cash reserves and may increase share-price volatility.
Important facts for investors to verify
- Confirm the reporting-period designation: this is the quarter ended December 31, 2021, not 2020 Q3.
- Assess whether revenue growth and the increase in claims activity are sustainable as pandemic-related recovery effects evolve.
- Track gross-margin trends, field headcount and labor costs, and the effect of network-solutions growth on margins.
- Reconcile operating cash flow’s year-over-year decline, including payroll-tax repayments, receivables, and customer-deposit movements.
- Monitor cash use and remaining authorization under the repurchase program, alongside capital spending and lease commitments.
- Review the uncertain potential effects of COVID-19, cybersecurity, regulatory changes, competition, and customer contract losses; the filing does not quantify their future financial impact.